UroGen Pharma Ltd. (URGN)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $33.75
- As of
Kresmion compiles this page from URGN's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
UroGen Pharma Ltd. (URGN): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-20.
See the full URGN dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for URGN on one page. Preview it with sample data, then open it live with a free account.
Preview the URGN dossierActive events for URGN
- high13F: funds reduced
3 tracked funds reduced URGN this 2026Q2, institutional consensus
- high13F: large increase
CITADEL ADVISORS LLC added +78% to URGN (2026Q2)
- high13F: large reduction
CITADEL ADVISORS LLC cut 54% of URGN (2026Q2)
- medium13F: new position
Point72 Asset Management, L.P. new position in URGN
- high13F: large reduction
MILLENNIUM MANAGEMENT LLC cut 71% of URGN (2026Q2)
FREE, NO ACCOUNT
Every event on URGN, as it fires
You are seeing 5 of 8 events recorded on URGN since 2026-06-01.
The five above landed across 2 days. The other 3 were recorded on 1 other days. 5 of the 8 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in URGN (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| Point72 Asset Management, L.P.CUSIP M96088105 · 2026Q2 | $56.1M | 0.06% | , |
| D. E. Shaw & Co., Inc.CUSIP M96088105 · 2026Q2 | $42.2M | 0.02% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP M96088105 · 2026Q2 | $5.5M | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP M96088105 · 2026Q2 | $3.9M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP M96088105 · 2026Q2 | $2.6M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP M96088105 · 2026Q2 | $478K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, URGN
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
Related tickers
Follow URGN on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to URGN for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.